Titan Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.54 |
Market Cap |
$98.08 M |
Shares Outstanding |
13.51 M |
Public Float |
12.42 M |
Address |
400 Oyster Point Boulevard South San Francisco California 94080 United States |
Employees | - |
Website | http://www.titanpharm.com |
Updated | 07/08/2019 |
Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing proprietary therapeutics primarily for the treatment of medical disorders. Its products include Probuphine, provides non fluctuating blood levels of buprenorphine; Ropinirole implant, which provides dopaminergic stimulation; and T3 implant, which is used in hypothyroidism treatment. Its products are subdermal implants, which utilizes ProNeura drug delivery platform. |